<i>Toxoplasma gondii</i> IgG Seroprevalence in Patients with HIV/AIDS
PDF
Cite
Share
Request
Original Investigation
P: 175-179
September 2018

Toxoplasma gondii IgG Seroprevalence in Patients with HIV/AIDS

Turkiye Parazitol Derg 2018;42(3):175-179
1. Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji, İstanbul, Türkiye
No information available.
No information available
Received Date: 06.11.2017
Accepted Date: 23.03.2018
PDF
Cite
Share
Request

ABSTRACT

Objective:

Toxoplasmosis is a common opportunistic infection in patients with HIV/AIDS and may cause life-threatening clinical courses, such as encephalitis and pneumonia.

Methods:

Patients admitted between January 2006 and August 2017 with anti-HIV positivity confirmed by Western blotting were included in the study. Demographic data, CD4+ T-lymphocyte counts, and Toxoplasma gondii IgG/IgM levels were retrospectively obtained from patient records.

Results:

T. gondii IgM positivity was not detected in patients, whereas T. gondii IgG positivity was detected in 267 (43.5%) patients. The T. gondii IgG positivity rate was 37.6% in men who had sex with men (MSM) and 48.4% in heterosexual patients. Furthermore, 42.6% of MSM and 21% of heterosexual patients were university graduates, of which T. gondii IgG positivity was detected in only 33.6% of MSM patients and 42.3% of heterosexual patients.

Conclusion:

In our study, high seronegativity was remarkable in MSM patients, particularly those who were highly educated, thus emphasizing the importance of prevention of primary infection in seronegative patients; necessity of prophylaxis in appropriate patients due to encephalitis, which has a high mortality rate and almost always develops after a latent infection; and necessity of screening for toxoplasmosis seropositivity at the time of diagnosis.

Keywords: HIV/AIDS, Toxoplasma gondii, seropositivity

References

2024 ©️ Galenos Publishing House